Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 1,621–1,680 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Uganda Heart Institute2 Uganda National Council for Science and Technology2 Unit2 United Kingdom Prospective Diabetes Study2 Unity Health Toronto2 Unity Health Toronto Research Ethics Board2 Universitair Ziekenhuis Brussel2 University Children’s Hospital in Belgrade2 University Clinical Center of Serbia2 University Hospital Coventry and Warwickshire2 University Hospital Essen2 University Hospital Galway2 University Hospital Zurich2 University Hospital of Modena2 University Hospital of North Norway2 University Hospitals Coventry and Warwickshire NHS Trust2 University Hospitals Sussex2 University Hospitals of North Midlands2 University Malaya Medical Centre2 University Medical Centre Utrecht2 University of Adelaide2 University of Amsterdam2 University of Athens2 University of Bonn2 University of Bristol2 University of Freiburg2 University of Galway2 University of Ghana2 University of Houston2 University of Lagos2 University of Leipzig2 University of Malaya Medical Centre2 University of Nairobi2 University of North Carolina2 University of North Carolina at Chapel Hill2 University of Nottingham2 University of Otago2 University of Ottawa2 University of Pretoria2 University of Queensland HREC2 University of Queensland Human Research Ethics Committee2 University of Regensburg2 University of Southampton2 University of Southern California2 University of Surrey2 University of Texas Health Science Center at Houston2 University of Toronto Health Sciences Research Ethics Board2 University of Utah Office of Comparative Medicine2 University of Washington Institutional Review Board2 University of Zambia2 University of the Witwatersrand2 Université du Québec à Rimouski2 Upper Gastrointestinal Cancer Early Detection Program2 Ural Children Eye Study2 Ural Eye and Medical Study2 Ural Very Old Study2 Valve Academic Research Consortium2 Vancouver General Hospital2 Vanderbilt University2 Vector Laboratories2

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 315 of 946

746 Post-transcriptional modulation of tapasin: Novel mechanisms driving immune escape, metastasis and tumor-immune cell crosstalk in melanoma

jitc · abstract · 2025-11-04 · 2 matching annotations

86.5%

TCGA-SKCM melanoma

…ression correlations and the prognostic impact were analyzed in TCGA-SKCM and independent in silico cohorts. Finally, the role of hnRNP C…

74 Automated co-detection of small RNAs, RNAs and proteins with Roche DISCOVERY™ ULTRA

jitc · abstract · 2025-11-04 · 2 matching annotations

90.1%

FDA Roche DISCOVERY™ ULTRA System neurodegenerative/neuromuscular disorders rare diseases FDA EMA

…nucleotide drug products have been commercially approved by the FDA and EMA, and many more are in clinical phase I-III trials. The …

755 CXCL13 as a biomarker of primary resistance to immunotherapy in non-small cell lung cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

90.5%

New England Journal of Medicine Non-small cell lung cancer non-small-cell lung cancer Pembrolizumab NSCLC nivolumab

…lumab and chemotherapy in stage III non-small-cell lung cancer. New England Journal of Medicine 2023;389:504–13.Gu X, Li D, Wu P, et al. Revisiting the CXCL13/…

78 Exploratory radiomics analysis in unresectable hepatocellular carcinoma treated with durvalumab alone or combined with tremelimumab or bevacizumab

jitc · abstract · 2025-11-04 · 2 matching annotations

82.4%

J Clin Oncol durvalumab bevacizumab tremelimumab hepatocellular carcinoma unresectable hepatocellular carcinoma HCC

…lar carcinoma: results from the phase 2 study 22 (NCT02519348). J Clin Oncol 2022; 40: abs 436.Ethics Approval This open-label, phase I/II s…

815 InTraSeq™ reveals novel transcriptomic and proteomic dynamics in activated CAR-T cells

jitc · abstract · 2025-11-04 · 2 matching annotations

95.4%

University of Pittsburgh Lohmueller Lab heme malignancies solid tumors Chimeric Antigen Receptor (CAR) T-cell therapy

…a Whitlow/218 linker was kindly provided by the Lohmueller Lab, University of Pittsburgh.Reference Ariss, M. M., Huang, L., Ding, X., Sheth, S., Levy, T…

817 Intratumoral CCR8+CD4+FoxP3+ regulatory T cell infiltration predicts inferior clinical outcomes but superior immunotherapeutic responsiveness in the patients with gastric cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

87.7%

Fudan University Zhongshan Hospital pembrolizumab pembrolizumab-based Gastric cancer PD-1 inhibitor CCR8 antagonist GC

…udy was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (No. B2024-261).Consent Written informed consent was obtained f…

842 Tox is overexpressed in HPV-associated head and neck squamous cell carcinoma compared to non-smoking and non-drinking, and smoking and drinking-related tumors: T cell overexhaustion?

jitc · abstract · 2025-11-04 · 2 matching annotations

95.4%

Huntsman Cancer Institute São Paulo Research Foundation head and neck squamous cell carcinoma (HNSCC)TOX HNSCC HPV-associated HNSCC University of Campinas Ethics Board

…s.Acknowledgements Biorepository and Molecular Pathology Core – Huntsman Cancer Institute, São Paulo Research Foundation - FAPESP, grant number: 2023/147…

854 Amplification & redirection of endogenous IL-15 activity with a bispecific antibody

jitc · abstract · 2025-11-04 · 2 matching annotations

80.5%

MC38 colorectal cancer cell line C57BL/6 mice pembrolizumab tumors Amplify•R

…tudies, C57BL/6 mice humanized for PD-1 were implanted with the MC38 colorectal cancer cell line, humanized for PD-L1. Antibody was administered subcutaneously …

855 Interim results from a comparative oncology safety study evaluating intravesical chitosan/interleukin-12 immunotherapy in client-owned dogs with invasive urothelial carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

91.8%

National Cancer Institute NC State University Invasive bladder cancer invasive urothelial carcinomaAbstract caIL-12 invasive urothelial carcinoma immunotherapy IL-12 U01CA272258 checkpoint inhibitors

…Acknowledgements This research is supported by a grant from the National Cancer Institute (U01CA272258).Ethics Approval Studies involving animals were ap…

876 Investigating the immune effects of radiation dose enhancement using internalized gold nanoparticles

jitc · abstract · 2025-11-04 · 2 matching annotations

81.3%

NIH National Institutes of Health cetuximab colorectal cancer cetuximab-conjugated cGNS

… The project is supported by the National Institutes of Health (NIH) R01 to SK (5R01CA257241-05).References Harding SM, Benci JL, I…

878 Pathway-synthetic senescence as a means to augment immunotherapy response

jitc · abstract · 2025-11-04 · 2 matching annotations

77.8%

Proc Natl Acad Sci U S A Cold Spring Harb Symp Quant Biol encorafenib dabrafenib pancreatic adenocarcinoma NRAS mutant melanoma BRAF inhibitors NRAS-mutant melanoma PDAC immunotherapy+2 more

…ooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2012;109,5934–5941.Abstract 878 Figure 1Paradoxical activation…

879 Local delivery of a plant virus immunotherapy with irreversible electroporation elicits dendritic cell activation and CD8 T cell infiltration in an orthotopic PDAC tumor model

jitc · abstract · 2025-11-04 · 2 matching annotations

92.2%

University of California San Diego The Jackson Laboratory pancreatic ductal adenocarcinoma (PDAC)PBS CPMV

…d by the Institutional Animal Care and Use Committee (IACUC) of University of California San Diego.Abstract 879 Figure 1IRE+CPMV treatment elicits antitumor immun…